NPEPPS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.719200E-01
Normal-vs-Stage2
8.306600E-01
Normal-vs-Stage3
1.189210E-01
Normal-vs-Stage4
7.919400E-01
Stage1-vs-Stage2
6.182600E-01
Stage1-vs-Stage3
1.342420E-01
Stage1-vs-Stage4
4.596200E-01
Stage2-vs-Stage3
9.340300E-02
Stage2-vs-Stage4
8.404400E-01
Stage3-vs-Stage4
1.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.446600E-01
Normal-vs-AfricanAmerican
9.523000E-01
Normal-vs-Asian
3.473800E-01
Caucasian-vs-AfricanAmerican
9.804600E-01
Caucasian-vs-Asian
4.193200E-01
AfricanAmerican-vs-Asian
6.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.229400E-01
Normal-vs-Female
8.301000E-01
Male-vs-Female
4.578400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.869400E-01
Normal-vs-Age(41-60Yrs)
1.633570E-02
Normal-vs-Age(61-80Yrs)
1.225390E-01
Normal-vs-Age(81-100Yrs)
4.402800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.558400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.571600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.162400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.825600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.348420E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.404600E-01
Normal-vs-Daily Drinker
2.699200E-01
Normal-vs-Weekly Drinker
4.203600E-01
Normal-vs-Occasional Drinker
8.609600E-02
Normal-vs-Social Drinker
5.998000E-01
Non Drinker-vs-Daily Drinker
2.890000E-01
Non Drinker-vs-Weekly Drinker
9.451800E-01
Non Drinker-vs-Occasional Drinker
6.998400E-03
Non Drinker-vs-Social Drinker
3.752300E-02
Daily Drinker-vs-Weekly Drinker
3.774800E-01
Daily Drinker-vs-Occasional Drinker
1.804850E-03
Daily Drinker-vs-Social Drinker
5.955200E-03
Weekly Drinker-vs-Occasional Drinker
1.670400E-02
Weekly Drinker-vs-Social Drinker
4.680200E-02
Occasional Drinker-vs-Social Drinker
4.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.504100E-02
Normal-vs-Grade 2
6.017700E-02
Normal-vs-Grade 3
7.443400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.863600E-01
Grade 1-vs-Grade 3
5.835500E-02
Grade 1-vs-Grade 4
9.504100E-02
Grade 2-vs-Grade 3
3.494000E-01
Grade 2-vs-Grade 4
6.017700E-02
Grade 3-vs-Grade 4
7.443400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.632200E-02
Normal-vs-NonDiabetic
8.777400E-01
Diabetic-vs-NonDiabetic
8.732300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.099400E-01
Normal-vs-NoPancreatitis
2.774400E-01
Pancreatitis-vs-NoPancreatitis
5.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.891200E-01
Normal-vs-N1
9.736600E-01
N0-vs-N1
5.420000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.165200E-01
Normal-vs-TP53-NonMutant
7.734400E-01
TP53-Mutant-vs-TP53-NonMutant
3.756400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
